Add BrightSurf on Google Email

Van Andel Institute, University of Freiburg study reveals insights into enzyme that combats a common greenhouse gas

Researchers at Van Andel Institute and University of Freiburg have discovered an enzyme that can break down nitrous oxide into harmless nitrogen and water. This breakthrough could potentially combat one of the main contributors to climate change, which accounts for only 7% of greenhouse gases but has a much greater impact.

SourceVan Andel Research Institute·JournalNature·TypeExperimental study·DateJul 27, 2022

Severe acute hepatitis of unknown causes in children is on the rise: A pediatric investigation review probes deeper for insights

A rise in severe acute hepatitis of unknown causes (SAHUC) in children has been reported worldwide, with symptoms including jaundice, vomiting, and diarrhea. Diagnostic tests such as liver enzymes and biopsy reports can help identify the disease, but its etiology remains unclear.

SourceCactus Communications·JournalPediatric Investigation·TypeSurvey·DateJul 19, 2022

Melioidosis: New target to combat a dangerous bacterial infection

A new therapeutic target for melioidosis has been identified by researchers at the Leibniz Institute for Natural Product Research and Infection Biology. The enzyme BurG synthesizes a toxic molecule central to infection, and inhibiting it could make bacteria less virulent.

What sea cucumbers can teach us about self-defense

Researchers have discovered how sea cucumbers produce defensive chemicals using genome mining techniques. The animals' unique ability to biosynthesize toxins has been found to be linked to the diversion of a sterol-producing enzyme, resulting in the production of valuable medicinal compounds.

SourceJohn Innes Centre·JournalNature Chemical Biology·TypeExperimental study·DateJun 27, 2022

Chinese Medical Journal Review shines a light on the overlooked virus, hepatitis D

Researchers discuss Hepatitis D's life cycle and interactions with its host, exploring strategies for further research to combat this overlooked virus. HDV coinfects people with hepatitis B, rapidly progressing to liver cirrhosis and cancer if left untreated, with a review published in the Chinese Medical Journal.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateJun 16, 2022

Overlooked proteins may be key to better diagnosis of Alzheimer’s

A recent study at UC San Francisco discovered that fragmented tau protein in diseased neurons could be a new target for existing drugs, potentially improving diagnosis and treatment of Alzheimer's. The researchers found that measuring the fragments in cerebrospinal fluid may help distinguish between different forms of dementia.

SourceUniversity of California - San Francisco·JournalNeuropathology and Applied Neurobiology·DateJun 2, 2022

Double agents: How stomach stem cells change allegiance upon injury

A molecular switch, p57, enables stomach stem cells to change allegiance from normal digestion to injury response, potentially leading to new treatments for gastric pathologies. The study's findings suggest that p57 is a key regulator of reserve stem cell state in gastric chief cells.

Researchers develop powerful strategy for creating new-to-nature enzymes

A team of researchers developed a simple yet powerful strategy for creating new enzymes with novel reactivity that can produce valuable chemical compounds. They used photobiocatalysis to repurpose naturally occurring enzymes and achieved an enantioselective biocatalytic reaction.

How a soil microbe could rev up artificial photosynthesis

A team of researchers discovered a soil microbe's enzyme that performs carbon fixation 20 times faster than plant enzymes. The enzyme consists of pairs of molecules working in sync to get the job done faster. This breakthrough could lead to more efficient artificial photosynthesis and produce fuels, fertilizers, and other products.

SourceDOE/SLAC National Accelerator Laboratory·JournalACS Central Science·TypeExperimental study·DateApr 29, 2022

Human cells’ emergency response could lead to better cancer treatment, research finds

Researchers found that a critical enzyme called AAG plays a crucial role in making cells respond to stress by communicating between different parts of the cell. This new understanding could lead to improved cancer treatments using alkylating agents, a class of drugs commonly used in chemotherapy.

SourceUniversity of Surrey·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 25, 2022

Research team from Goethe University discovers Achilles’ heel of dangerous hospital pathogen

A team from Goethe University has identified the spatial structure of the mannitol-synthesizing enzyme MtlD in Acinetobacter baumannii, which is crucial for its survival. This discovery could lead to the development of customized substances to inhibit the enzyme and combat this hospital pathogen.

SourceGoethe University Frankfurt·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 6, 2022

The nanodrug that attacks the cancer twice A single nanoparticle does two jobs: enhancing the effectiveness of chemotherapy and reinvigorating the immune system

Researchers at Tel Aviv University developed a drug delivery system based on lipid nanoparticles that utilize RNA to boost personalized cancer care. The nanodrug enhances chemotherapy effectiveness and reinvigorates the immune system, increasing sensitivity to cancer cells.

SourceTel-Aviv University·JournalScience Advances·DateApr 4, 2022

How a particular protein regulates up to two-thirds of the world’s methane emission: key mechanism for methane emission in anaerobic environments is now understood, potentially helping the fight against climate change.

Researchers have deciphered the activity of B12-dependent radical SAM enzymes, which regulate methane production by archaea. The study's findings have implications for biotechnologies that control key enzymatic events and could help reduce global warming.

SourceNagoya University·JournalNature·TypeImaging analysis·DateMar 17, 2022

Baby white wallaby harboring hopping DNA

Researchers at Kyoto University have identified a genetic mutation causing albinism in wallabies, tracing it to an inserted retrovirus gene. The study found that the mutation was caused by a copy of the HIV-like virus inserted into the host's genome.

SourceKyoto University·JournalGenome·TypeExperimental study·DateMar 10, 2022

Novel enzyme catalyzing the formation of glycosidic bonds in complex sugar moieties characterized

Researchers have identified a novel enzyme that catalyzes the formation of glycosidic bonds in complex sugar moieties. The discovery provides fresh insights into carbohydrate metabolism and offers a breakthrough for the synthesis of sugar chains, which play key roles in various biological processes.

SourceTokyo University of Science·JournalJournal of Biological Chemistry·TypeExperimental study·DateMar 7, 2022

Cannabinoids from amoebae

A research team at Leibniz-HKI has developed a new method to produce complex natural products, including the precursor to THC, in amoebae. By leveraging the natural properties of the amoeba, they were able to produce a functional inter-kingdom hybrid enzyme that produces olivetolic acid without additives.

Herbs that protect the heart: Bilobalide reduces cardiac damage in myocardial ischemia, says new study in Journal of Pharmaceutical Analysis

Researchers found that bilobalide, an active ingredient in Ginkgo biloba extract, protects the heart from ischemic injuries by preserving ATP generation and enhancing metabolic flux. The study suggests that bilobalide may provide a new herbal therapy for treating myocardial ischemia.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateFeb 24, 2022